Patient-safety harm from model error
A wrong or missed prediction can directly affect diagnosis and treatment — the highest-stakes failure mode of all.
ISO/IEC 42001 by industry
ISO/IEC 42001 for healthcare & medical AI
AI supports diagnosis, triage, imaging, clinical decisions and patient administration — where an error is a patient-safety event, not a bug ticket. ISO/IEC 42001 gives healthcare providers and medical-AI developers an auditable governance system that sits alongside MDR/IVDR, patient-safety and health-data obligations.
Why this is high-risk
EU AI Act — Annex I & Annex III, high-risk
Medical AI carries the strictest compliance load
AI that is a safety component of a medical device or in-vitro diagnostic falls under the EU AI Act's product route (Annex I), tied to MDR/IVDR conformity — these obligations apply from 2 August 2028. AI used to triage or dispatch emergency healthcare is high-risk under Annex III. On top of the AI Act sit MDR/IVDR technical documentation and clinical evaluation, medicines-agency and FDA expectations for software as a medical device, patient-safety duties, and GDPR's special-category health-data rules. ISO 42001 complements the device route — it does not replace it — by governing the AI management system around it.
The risks
Where medical AI creates exposure
In healthcare the cost of getting AI governance wrong is measured in patient harm:
Demographic bias in clinical models
Datasets that under-represent groups produce models that perform worse for them, deepening health inequities.
Data provenance and quality
Clinical training data with unclear origin, consent basis or quality undermines both safety and lawfulness.
Clinician over-reliance
Automation bias — clinicians deferring to AI without meaningful review — erodes the human oversight the law requires.
Post-market drift
Model performance degrades as populations, devices and practice change; without monitoring it goes unnoticed.
Explainability to clinicians and patients
Decisions that can't be explained are hard to trust, act on, or defend.
How ISO/IEC 42001 covers it
The controls and templates that matter most here
The toolkit maps each risk to a specific Annex A control and a ready-made document:
| Annex A control | Toolkit document | Why it matters |
|---|---|---|
| A.5 — Impact assessment | AI Impact Assessment (RISK-TPL-01) | Assess effects on patients and clinicians before deployment — feeds directly into MDR clinical and risk documentation. |
| A.6 — Lifecycle & validation | V&V Plan and Report + Model Card + Technical Documentation Pack (VV-PLN-01 / VV-REC-01 / LIFE-TPL-05 / LIFE-TPL-04) | Rigorous validation and documentation that align with device technical files. |
| A.7 — Data quality, provenance & bias | Data Quality Assessment + Provenance Log + Bias and Fairness Record (DATA-TPL-03 / DATA-TPL-02 / DATA-TPL-05) | Demonstrate representative, well-sourced, lawful clinical data and monitored fairness across groups. |
| A.9.3 — Human oversight | Human Oversight Plan (USE-PLN-01) | Keep a clinician meaningfully in the loop and guard against automation bias. |
| A.6.2 / Clause 9 — Monitoring | Monitoring Plan & KPI Register (MON-PLN-01) | Post-market performance monitoring and drift detection — expected by both the AI Act and device regulators. |
| A.8.4 — Incident response | AI Incident Response Procedure (INC-PRO-01) | A defined severity and escalation workflow for safety-relevant AI events, with evidence preservation. |
How to get there
From clinical AI to an auditable, safe system
- 1
Register every clinical and administrative AI system, with an owner and a link to any device conformity file.
- 2
Run impact, bias and data-quality assessments; validate and document each model.
- 3
Embed clinician oversight, transparency and a safety-grade incident process.
- 4
Monitor post-market performance and drift, and align the AIMS with MDR/IVDR evidence.
Questions
Healthcare & medical AI — quick answers
Does ISO 42001 replace MDR/IVDR or FDA clearance?
No. Medical-device AI still needs its regulatory route. ISO 42001 governs the AI management system around the device — impact and bias assessment, data governance, oversight, monitoring and incident response — and its evidence complements the technical documentation those routes require.
When do the AI Act obligations apply to medical AI?
AI that is a safety component of a device under MDR/IVDR follows the product route with obligations from 2 August 2028; emergency-triage AI is Annex III with obligations from 2 December 2027. The substantive requirements are unchanged — the runway is for building the system.
We're a hospital using bought clinical AI, not a manufacturer — does this apply?
Yes. As a deployer you're responsible for human oversight, monitoring, and using the AI within its intended use. ISO 42001 gives providers the deployer-side controls to do this defensibly.
Govern medical AI to a patient-safety standard
The toolkit ships the impact, validation, data-quality, oversight, monitoring and incident controls medical AI demands — ready to tailor and to sit alongside your device documentation.